Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission.
Holtick U, Shimabukuro-Vornhagen A, Chakupurakal G, Theurich S, Leitzke S, Burst A, Hallek M, von Bergwelt-Baildon M, Scheid C, Chemnitz JM. Holtick U, et al. Among authors: leitzke s. Eur J Haematol. 2016 May;96(5):475-82. doi: 10.1111/ejh.12615. Epub 2015 Aug 25. Eur J Haematol. 2016. PMID: 26132980
Nonmyeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia offers the possibility of disease control with minimal morbidity and mortality--a single institution experience.
Chakupurakal G, Leitzke S, Langerbeins P, Schiller J, Schneider PM, Holtick U, Shimabukuro-Vornhagen A, Theurich S, Chemnitz J, Hallek M, von Bergwelt-Baildon M, Scheid C. Chakupurakal G, et al. Among authors: leitzke s. Ann Hematol. 2015 Oct;94(10):1717-25. doi: 10.1007/s00277-015-2449-1. Epub 2015 Aug 12. Ann Hematol. 2015. PMID: 26259502
Pretransplant comorbidities maintain their impact on allogeneic stem cell transplantation outcome 5 years posttransplant: a retrospective study in a single german institution.
Chemnitz JM, Chakupurakal G, Bäßler M, Holtick U, Theurich S, Shimabukuro-Vornhagen A, Leitzke S, Von Bergwelt-Baildon MS, Scheid C. Chemnitz JM, et al. Among authors: leitzke s. ISRN Hematol. 2014 Mar 5;2014:853435. doi: 10.1155/2014/853435. eCollection 2014. ISRN Hematol. 2014. PMID: 24729881 Free PMC article.
Scramblases as Regulators of Proteolytic ADAM Function.
Reiss K, Leitzke S, Seidel J, Sperrhacke M, Bhakdi S. Reiss K, et al. Among authors: leitzke s. Membranes (Basel). 2022 Feb 4;12(2):185. doi: 10.3390/membranes12020185. Membranes (Basel). 2022. PMID: 35207106 Free PMC article. Review.
Role of ADAM10 and ADAM17 in Regulating CD137 Function.
Seidel J, Leitzke S, Ahrens B, Sperrhacke M, Bhakdi S, Reiss K. Seidel J, et al. Among authors: leitzke s. Int J Mol Sci. 2021 Mar 8;22(5):2730. doi: 10.3390/ijms22052730. Int J Mol Sci. 2021. PMID: 33800462 Free PMC article.
14 results